版本:
中国

BRIEF-U.S. FDA says issued a warning letter to Abbott Laboratories

April 13 U.S. Food and Drug Administration :

* Says issued a warning letter to Abbott Laboratories

* Says raises quality concerns after inspection of St. Jude's Sylmar facility

* Says to Abbott failure to correct violations may result in regulatory action without further notice Source text - bit.ly/2pw2NlM Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐